ArticleJournal of hematology & oncology2019

Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).

Francesco Saraceni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.